1. Home
  2. Material Detail: Parkinson's: Study reveals how cancer drug reduces toxic protein in brain

Material Detail

"Parkinson's: Study reveals how cancer drug reduces toxic protein in brain" icon

Parkinson's: Study reveals how cancer drug reduces toxic protein in brain

An analysis of trial results reveals the mechanism through which the cancer drug nilotinib increases brain dopamine in people with Parkinson's disease.

Disciplines:
Go to Material 
Bookmark / Add to Course ePortfolio
Create a Learning Exercise
Add Accessibility Information
Rate
Add a Comment

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collection (1) Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Material Type:
Open (Access) Journal-Article
Date Added to MERLOT:
March 21, 2019
Date Modified in MERLOT:
May 9, 2021
Author:
Unknown (Know the author?)
Submitter:
Ashley Fink
Primary Audience:
College General Ed, College Upper Division, Professional
Technical Format:
Website
Mobile Compatibility:
Not specified at this time
Language:
English
Cost Involved:
Unknown
Source Code Available:
Unknown
Creative Commons:
Unknown

Browse...

Disciplines with similar materials as Parkinson's: Study reveals how cancer drug reduces toxic protein in brain
People who viewed this also viewed
Other materials like Parkinson's: Study reveals how cancer drug reduces toxic protein in brain

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.